(2R)-2-[[2-[[(2R)-5-(diaminomethylideneamino)-2-[[(4S,6R,12S,15R,16S)-4-hydroxy-12-(2-methylpropyl)-3-oxo-15-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]-9,16-di(propan-2-yl)-8,11,14-trioxa-2,7,10,13-tetrazatricyclo[15.3.1.04,20]henicosa-1(20),17(21),18-triene-6-carbonyl]amino]pentanoyl]amino]acetyl]amino]-3-(1H-imidazol-5-yl)propanoic acid
Internal ID | 42d72e65-9fce-49f5-8946-37c57599e5b6 |
Taxonomy | Organic acids and derivatives > Carboxylic acids and derivatives > Amino acids, peptides, and analogues > Peptides > Oligopeptides |
IUPAC Name | (2R)-2-[[2-[[(2R)-5-(diaminomethylideneamino)-2-[[(4S,6R,12S,15R,16S)-4-hydroxy-12-(2-methylpropyl)-3-oxo-15-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]-9,16-di(propan-2-yl)-8,11,14-trioxa-2,7,10,13-tetrazatricyclo[15.3.1.04,20]henicosa-1(20),17(21),18-triene-6-carbonyl]amino]pentanoyl]amino]acetyl]amino]-3-(1H-imidazol-5-yl)propanoic acid |
SMILES (Canonical) | CC(C)CC1NOC(C(C2=CC3=C(C=C2)C(CC(NOC(NO1)C(C)C)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)NC(CC4=CN=CN4)C(=O)O)(C(=O)N3)O)C(C)C)NC(=O)C5CCC(=O)N5 |
SMILES (Isomeric) | CC(C)C[C@H]1NO[C@H]([C@H](C2=CC3=C(C=C2)[C@@](C[C@@H](NOC(NO1)C(C)C)C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@H](CC4=CN=CN4)C(=O)O)(C(=O)N3)O)C(C)C)NC(=O)[C@@H]5CCC(=O)N5 |
InChI | InChI=1S/C44H68N14O12/c1-21(2)14-34-57-70-40(55-37(62)28-11-12-32(59)51-28)35(22(3)4)24-9-10-26-29(15-24)54-42(66)44(26,67)17-31(56-69-39(23(5)6)58-68-34)38(63)53-27(8-7-13-48-43(45)46)36(61)49-19-33(60)52-30(41(64)65)16-25-18-47-20-50-25/h9-10,15,18,20-23,27-28,30-31,34-35,39-40,56-58,67H,7-8,11-14,16-17,19H2,1-6H3,(H,47,50)(H,49,61)(H,51,59)(H,52,60)(H,53,63)(H,54,66)(H,55,62)(H,64,65)(H4,45,46,48)/t27-,28+,30-,31-,34+,35+,39?,40-,44+/m1/s1 |
InChI Key | YMJBRTYSEFIODE-ORDFBPPRSA-N |
Popularity | 0 references in papers |
Molecular Formula | C44H68N14O12 |
Molecular Weight | 985.10 g/mol |
Exact Mass | 984.51411366 g/mol |
Topological Polar Surface Area (TPSA) | 389.00 Ų |
XlogP | -2.60 |
Atomic LogP (AlogP) | -1.83 |
H-Bond Acceptor | 16 |
H-Bond Donor | 14 |
Rotatable Bonds | 19 |
There are no found synonyms. |
![2D Structure of (2R)-2-[[2-[[(2R)-5-(diaminomethylideneamino)-2-[[(4S,6R,12S,15R,16S)-4-hydroxy-12-(2-methylpropyl)-3-oxo-15-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]-9,16-di(propan-2-yl)-8,11,14-trioxa-2,7,10,13-tetrazatricyclo[15.3.1.04,20]henicosa-1(20),17(21),18-triene-6-carbonyl]amino]pentanoyl]amino]acetyl]amino]-3-(1H-imidazol-5-yl)propanoic acid 2D Structure of (2R)-2-[[2-[[(2R)-5-(diaminomethylideneamino)-2-[[(4S,6R,12S,15R,16S)-4-hydroxy-12-(2-methylpropyl)-3-oxo-15-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]-9,16-di(propan-2-yl)-8,11,14-trioxa-2,7,10,13-tetrazatricyclo[15.3.1.04,20]henicosa-1(20),17(21),18-triene-6-carbonyl]amino]pentanoyl]amino]acetyl]amino]-3-(1H-imidazol-5-yl)propanoic acid](https://plantaedb.com/storage/docs/compounds/2023/11/a86c57d0-84af-11ee-8f70-e9788b16fe09.jpg)
Target | Value | Probability (raw) | Probability (%) |
---|---|---|---|
Human Intestinal Absorption | + | 0.7690 | 76.90% |
Caco-2 | - | 0.8641 | 86.41% |
Blood Brain Barrier | - | 0.6750 | 67.50% |
Human oral bioavailability | - | 0.5429 | 54.29% |
Subcellular localzation | Mitochondria | 0.3773 | 37.73% |
OATP2B1 inhibitior | - | 0.8569 | 85.69% |
OATP1B1 inhibitior | + | 0.7897 | 78.97% |
OATP1B3 inhibitior | + | 0.9349 | 93.49% |
MATE1 inhibitior | - | 0.7200 | 72.00% |
OCT2 inhibitior | - | 0.7000 | 70.00% |
BSEP inhibitior | + | 0.9782 | 97.82% |
P-glycoprotein inhibitior | + | 0.7478 | 74.78% |
P-glycoprotein substrate | + | 0.8379 | 83.79% |
CYP3A4 substrate | + | 0.7478 | 74.78% |
CYP2C9 substrate | - | 1.0000 | 100.00% |
CYP2D6 substrate | - | 0.8614 | 86.14% |
CYP3A4 inhibition | - | 0.6934 | 69.34% |
CYP2C9 inhibition | - | 0.7814 | 78.14% |
CYP2C19 inhibition | - | 0.7594 | 75.94% |
CYP2D6 inhibition | - | 0.8943 | 89.43% |
CYP1A2 inhibition | - | 0.8013 | 80.13% |
CYP2C8 inhibition | + | 0.8232 | 82.32% |
CYP inhibitory promiscuity | - | 0.9221 | 92.21% |
UGT catelyzed | - | 0.5000 | 50.00% |
Carcinogenicity (binary) | - | 0.8400 | 84.00% |
Carcinogenicity (trinary) | Non-required | 0.4811 | 48.11% |
Eye corrosion | - | 0.9801 | 98.01% |
Eye irritation | - | 0.9005 | 90.05% |
Skin irritation | - | 0.7619 | 76.19% |
Skin corrosion | - | 0.9192 | 91.92% |
Ames mutagenesis | - | 0.6000 | 60.00% |
Human Ether-a-go-go-Related Gene inhibition | + | 0.6513 | 65.13% |
Micronuclear | + | 0.8300 | 83.00% |
Hepatotoxicity | + | 0.5033 | 50.33% |
skin sensitisation | - | 0.8255 | 82.55% |
Respiratory toxicity | + | 0.8000 | 80.00% |
Reproductive toxicity | + | 0.8333 | 83.33% |
Mitochondrial toxicity | + | 0.8250 | 82.50% |
Nephrotoxicity | - | 0.8429 | 84.29% |
Acute Oral Toxicity (c) | III | 0.5568 | 55.68% |
Estrogen receptor binding | + | 0.7662 | 76.62% |
Androgen receptor binding | + | 0.7389 | 73.89% |
Thyroid receptor binding | + | 0.5934 | 59.34% |
Glucocorticoid receptor binding | + | 0.5771 | 57.71% |
Aromatase binding | + | 0.6963 | 69.63% |
PPAR gamma | + | 0.7758 | 77.58% |
Honey bee toxicity | - | 0.6837 | 68.37% |
Biodegradation | - | 0.8250 | 82.50% |
Crustacea aquatic toxicity | - | 0.5900 | 59.00% |
Fish aquatic toxicity | + | 0.7411 | 74.11% |
Proven Targets:
CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
---|---|---|---|---|---|
No proven targets yet! |
Predicted Targets (via Super-PRED):
CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
---|---|---|---|---|
CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 99.36% | 91.11% |
CHEMBL2581 | P07339 | Cathepsin D | 99.27% | 98.95% |
CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 99.06% | 94.45% |
CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 98.54% | 96.09% |
CHEMBL3137262 | O60341 | LSD1/CoREST complex | 97.02% | 97.09% |
CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 96.83% | 90.71% |
CHEMBL2492 | P36544 | Neuronal acetylcholine receptor protein alpha-7 subunit | 96.72% | 88.42% |
CHEMBL259 | P32245 | Melanocortin receptor 4 | 95.90% | 95.38% |
CHEMBL230 | P35354 | Cyclooxygenase-2 | 95.01% | 89.63% |
CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 93.94% | 97.23% |
CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 93.94% | 98.33% |
CHEMBL1075094 | Q16236 | Nuclear factor erythroid 2-related factor 2 | 93.44% | 96.00% |
CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 92.74% | 93.56% |
CHEMBL4608 | P33032 | Melanocortin receptor 5 | 92.68% | 97.00% |
CHEMBL2535 | P11166 | Glucose transporter | 92.19% | 98.75% |
CHEMBL3038477 | P67870 | Casein kinase II alpha/beta | 92.16% | 99.23% |
CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 92.00% | 99.17% |
CHEMBL221 | P23219 | Cyclooxygenase-1 | 91.82% | 90.17% |
CHEMBL2815 | P04629 | Nerve growth factor receptor Trk-A | 91.57% | 87.16% |
CHEMBL2514 | O95665 | Neurotensin receptor 2 | 91.07% | 100.00% |
CHEMBL4644 | P41968 | Melanocortin receptor 3 | 90.41% | 99.52% |
CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 89.58% | 97.64% |
CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 89.16% | 95.89% |
CHEMBL4685 | P14902 | Indoleamine 2,3-dioxygenase | 89.01% | 96.38% |
CHEMBL204 | P00734 | Thrombin | 88.95% | 96.01% |
CHEMBL4777 | P25929 | Neuropeptide Y receptor type 1 | 88.72% | 96.67% |
CHEMBL3310 | Q96DB2 | Histone deacetylase 11 | 88.53% | 88.56% |
CHEMBL2413 | P32246 | C-C chemokine receptor type 1 | 87.34% | 89.50% |
CHEMBL4227 | P25090 | Lipoxin A4 receptor | 86.38% | 100.00% |
CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 86.17% | 95.00% |
CHEMBL2179 | P04062 | Beta-glucocerebrosidase | 86.07% | 85.31% |
CHEMBL3267 | P48736 | PI3-kinase p110-gamma subunit | 85.97% | 95.71% |
CHEMBL4979 | P13866 | Sodium/glucose cotransporter 1 | 85.84% | 98.24% |
CHEMBL2553 | Q15418 | Ribosomal protein S6 kinase alpha 1 | 85.60% | 85.11% |
CHEMBL4026 | P40763 | Signal transducer and activator of transcription 3 | 85.30% | 82.69% |
CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 85.08% | 90.08% |
CHEMBL5028 | O14672 | ADAM10 | 84.90% | 97.50% |
CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 84.87% | 96.47% |
CHEMBL1744525 | P43490 | Nicotinamide phosphoribosyltransferase | 84.77% | 96.25% |
CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 84.64% | 95.56% |
CHEMBL1907603 | Q05586 | Glutamate NMDA receptor; GRIN1/GRIN2B | 82.75% | 95.89% |
CHEMBL1255126 | O15151 | Protein Mdm4 | 82.74% | 90.20% |
CHEMBL255 | P29275 | Adenosine A2b receptor | 82.13% | 98.59% |
CHEMBL5939 | Q9NZ08 | Endoplasmic reticulum aminopeptidase 1 | 82.10% | 100.00% |
CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 81.40% | 94.66% |
CHEMBL1907600 | Q00535 | Cyclin-dependent kinase 5/CDK5 activator 1 | 81.25% | 93.03% |
CHEMBL2094135 | Q96BI3 | Gamma-secretase | 80.28% | 98.05% |
CHEMBL1628481 | P35414 | Apelin receptor | 80.16% | 97.89% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
Celosia argentea |
PubChem | 101344858 |
LOTUS | LTS0242330 |
wikiData | Q105350564 |